Thomas Amann

1.8k total citations
28 papers, 1.4k citations indexed

About

Thomas Amann is a scholar working on Molecular Biology, Cancer Research and Epidemiology. According to data from OpenAlex, Thomas Amann has authored 28 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Molecular Biology, 9 papers in Cancer Research and 4 papers in Epidemiology. Recurrent topics in Thomas Amann's work include Cancer, Hypoxia, and Metabolism (9 papers), Metabolism, Diabetes, and Cancer (7 papers) and Viral Infectious Diseases and Gene Expression in Insects (5 papers). Thomas Amann is often cited by papers focused on Cancer, Hypoxia, and Metabolism (9 papers), Metabolism, Diabetes, and Cancer (7 papers) and Viral Infectious Diseases and Gene Expression in Insects (5 papers). Thomas Amann collaborates with scholars based in Germany, Denmark and United States. Thomas Amann's co-authors include Claus Hellerbrand, Jürgen Schölmerich, Anja‐Katrin Bosserhoff, Thomas S. Weiß, Thilo Spruß, Ulrike Maegdefrau, Christina Warnecke, Frauke Bataille, Peter J. Oefner and Marcus Mühlbauer and has published in prestigious journals such as PLoS ONE, Applied and Environmental Microbiology and Gut.

In The Last Decade

Thomas Amann

26 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Thomas Amann Germany 17 806 452 329 284 238 28 1.4k
Arsen Mikaelyan Russia 10 747 0.9× 381 0.8× 221 0.7× 487 1.7× 296 1.2× 26 1.4k
Hengjun Gao China 25 1.1k 1.4× 670 1.5× 239 0.7× 122 0.4× 309 1.3× 72 1.6k
Sandrine Boyault France 14 1.0k 1.2× 503 1.1× 298 0.9× 503 1.8× 351 1.5× 20 1.7k
Tong‐Chun Xue China 22 466 0.6× 321 0.7× 208 0.6× 405 1.4× 501 2.1× 41 1.3k
Coral Ho United States 19 1.4k 1.7× 592 1.3× 226 0.7× 253 0.9× 577 2.4× 21 2.1k
Shuhei Yoshida Japan 16 563 0.7× 196 0.4× 377 1.1× 429 1.5× 264 1.1× 77 1.4k
Le‐Qun Li China 20 685 0.8× 598 1.3× 229 0.7× 312 1.1× 542 2.3× 63 1.5k
Jack Leslie United Kingdom 17 396 0.5× 208 0.5× 260 0.8× 203 0.7× 184 0.8× 34 1.1k
Yuezhen Deng China 20 1.1k 1.4× 646 1.4× 189 0.6× 173 0.6× 421 1.8× 34 1.8k
Daimin Xiang China 17 1.2k 1.5× 764 1.7× 200 0.6× 268 0.9× 301 1.3× 28 1.6k

Countries citing papers authored by Thomas Amann

Since Specialization
Citations

This map shows the geographic impact of Thomas Amann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Amann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Amann more than expected).

Fields of papers citing papers by Thomas Amann

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas Amann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Amann. The network helps show where Thomas Amann may publish in the future.

Co-authorship network of co-authors of Thomas Amann

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas Amann. A scholar is included among the top collaborators of Thomas Amann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas Amann. Thomas Amann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Amann, Thomas, Anders Holmgaard Hansen, Stefan Kol, et al.. (2018). Glyco-engineered CHO cell lines producing alpha-1-antitrypsin and C1 esterase inhibitor with fully humanized N-glycosylation profiles. Metabolic Engineering. 52. 143–152. 39 indexed citations
2.
Amann, Thomas, et al.. (2018). Targeting miRNAs with CRISPR/Cas9 to Improve Recombinant Protein Production of CHO Cells. Methods in molecular biology. 1850. 221–235. 10 indexed citations
3.
Engelmann, Julia C., Thomas Amann, Yvonne Reinders, et al.. (2015). Causal Modeling of Cancer-Stromal Communication Identifies PAPPA as a Novel Stroma-Secreted Factor Activating NFκB Signaling in Hepatocellular Carcinoma. PLoS Computational Biology. 11(5). e1004293–e1004293. 20 indexed citations
4.
Riener, Marc‐Oliver, Thore Thiesler, Claus Hellerbrand, et al.. (2014). Loss of Anterior Gradient-2 expression is an independent prognostic factor in colorectal carcinomas. European Journal of Cancer. 50(10). 1722–1730. 16 indexed citations
5.
Schmidt, Jennifer V., Raphael Stoll, Thomas Amann, et al.. (2012). Targeting Melanoma Metastasis and Immunosuppression with a New Mode of Melanoma Inhibitory Activity (MIA) Protein Inhibition. PLoS ONE. 7(5). e37941–e37941. 22 indexed citations
6.
Amann, Thomas, Georgi Kirovski, Anja‐Katrin Bosserhoff, & Claus Hellerbrand. (2011). Analysis of a promoter polymorphism of the GLUT1 gene in patients with hepatocellular carcinoma. Molecular Membrane Biology. 28(3). 182–186. 15 indexed citations
7.
Walter, Roland B., Josef Wanninger, Sabrina Bauer, et al.. (2011). Adiponectin reduces connective tissue growth factor in human hepatocytes which is already induced in non-fibrotic non-alcoholic steatohepatitis. Experimental and Molecular Pathology. 91(3). 740–744. 20 indexed citations
8.
Amann, Thomas, Frauke Bataille, Thilo Spruß, et al.. (2010). Reduced Expression of Fibroblast Growth Factor Receptor 2IIIb in Hepatocellular Carcinoma Induces a More Aggressive Growth. American Journal Of Pathology. 176(3). 1433–1442. 52 indexed citations
9.
Amann, Thomas, Georgi Kirovski, Anja‐Katrin Bosserhoff, & Claus Hellerbrand. (2010). Analysis of a promoter polymorphism of the GLUT1 gene in patients with hepatocellular carcinoma. Zeitschrift für Gastroenterologie. 48(1).
10.
Amann, Thomas, Frauke Bataille, Thilo Spruß, et al.. (2009). Activated hepatic stellate cells promote tumorigenicity of hepatocellular carcinoma. Cancer Science. 100(4). 646–653. 223 indexed citations
11.
Maegdefrau, Ulrike, Thomas Amann, Simone Braig, et al.. (2009). Bone morphogenetic protein 4 is induced in hepatocellular carcinoma by hypoxia and promotes tumour progression. The Journal of Pathology. 218(4). 520–529. 73 indexed citations
12.
Amann, Thomas, Ulrike Maegdefrau, Arndt Hartmann, et al.. (2009). GLUT1 Expression Is Increased in Hepatocellular Carcinoma and Promotes Tumorigenesis. American Journal Of Pathology. 174(4). 1544–1552. 298 indexed citations
13.
Amann, Thomas & Claus Hellerbrand. (2009). GLUT1 as a therapeutic target in hepatocellular carcinoma. Expert Opinion on Therapeutic Targets. 13(12). 1411–1427. 168 indexed citations
14.
Wobser, H, Christoph Dorn, Thomas S. Weiß, et al.. (2009). Lipid accumulation in hepatocytes induces fibrogenic activation of hepatic stellate cells. Cell Research. 19(8). 996–1005. 201 indexed citations
15.
Hergan, Klaus, Thomas Amann, & W. Oser. (2008). Sonopathologie der Axilla - I. Teil. Ultraschall in der Medizin - European Journal of Ultrasound. 14(4). 154–162.
16.
Amann, Thomas, A. Hartmann, Jürgen Schölmerich, Anja‐Katrin Bosserhoff, & Claus Hellerbrand. (2008). GLUT1 expression is increased in hepatocellular carcinoma and promotes tumorigenesis. Zeitschrift für Gastroenterologie. 46(1). 8 indexed citations
17.
Hellerbrand, Claus, Thomas Amann, Jürgen Schlegel, et al.. (2007). The novel gene MIA2 acts as a tumour suppressor in hepatocellular carcinoma. Gut. 57(2). 243–251. 59 indexed citations
18.
Henneberger, Ruth, Christine Moissl‐Eichinger, Thomas Amann, Christian Rudolph, & Robert Huber. (2006). New Insights into the Lifestyle of the Cold-Loving SM1 Euryarchaeon: Natural Growth as a Monospecies Biofilm in the Subsurface. Applied and Environmental Microbiology. 72(1). 192–199. 32 indexed citations
19.
Felbor, Ute, Heidi Stöhr, Thomas Amann, et al.. (1996). A second independent Tyr168Cys mutation in the tissue inhibitor of metalloproteinases-3 (TIMP3) in Sorsby's fundus dystrophy.. Journal of Medical Genetics. 33(3). 233–236. 28 indexed citations
20.
Felbor, Ute, et al.. (1995). A novel Ser156Cys mutation in the tissue inhibitor of metalloproteinases-3 (TIMP3) in Sorsby's fundus dystrophy with unusual clinical features. Human Molecular Genetics. 4(12). 2415–2416. 61 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Arsen Mikaelyan Breakdown of academic impact, for papers by Hengjun Gao Breakdown of academic impact, for papers by Sandrine Boyault Breakdown of academic impact, for papers by Tong‐Chun Xue Breakdown of academic impact, for papers by Coral Ho Breakdown of academic impact, for papers by Shuhei Yoshida Breakdown of academic impact, for papers by Le‐Qun Li Breakdown of academic impact, for papers by Jack Leslie Breakdown of academic impact, for papers by Yuezhen Deng Breakdown of academic impact, for papers by Daimin Xiang
Rankless by CCL
2026